| mRNA |
ML203 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
| mRNA |
neratinib |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
| mRNA |
Docetaxel |
gCSI |
pan-cancer |
AAC |
-0.16 |
0.003 |
| mRNA |
Gemcitabine |
gCSI |
pan-cancer |
AAC |
-0.16 |
0.004 |
| mRNA |
Erlotinib |
GDSC1000 |
pan-cancer |
AAC |
0.14 |
0.006 |
| mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.09 |
0.009 |
| mRNA |
YM-155 |
CTRPv2 |
pan-cancer |
AAC |
-0.095 |
0.01 |
| mRNA |
nelarabine |
CTRPv2 |
pan-cancer |
AAC |
0.096 |
0.01 |
| mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.088 |
0.01 |
| mRNA |
BRD9876:MK-1775 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.29 |
0.01 |